Key result
Innate and adaptive immune mechanisms drive the pathophysiology of essential hypertension and end-organ damage.
Answers are grounded in this paper and cite their sources.
Hypertension (HTN) is a critical worldwide health issue and an imperative risk factor for the development of cardiovascular disease and kidney disease. There are many crevices in our knowledge about the pathophysiology of HTN. The mechanisms intervening in HTN are complex. In recent years, a large scale of evidence supports the role of various components of the innate and adaptive immune systems (such as immune cells subsets, cytokines, complement system, and toll-like receptors) as contributors to HTN and developed end-organ damage. The endpoint of all these pathways is to develop an inflammatory condition that leads to HTN and damage to the end organ. Despite the availability of different antihypertensive drugs, there are still many patients with persistent or uncontrolled HTN. Therefore, understanding these immune pathways and their effects on patients with resistant hypertension. In addition, finding the detailed immunopathogenesis may help us find more targeted therapeutic approaches and improve cardiovascular and renal function in this high-risk untreated population. This review article summarizes different conducted studies on immunity and HTN that indicate the basic role of the immune system in causing HTN.
No takes yet. Share an insight, caveat, or question.
Rekabi et al. (2022) conducted a review in Essential Hypertension. Immune system components was evaluated. Various components of the innate and adaptive immune systems contribute to the pathophysiology of essential hypertension and subsequent end-organ damage.
Synapse has enriched 10 related papers. Consider them for comparative context: